Insider · CIK 0002115494
BSG Series CM, LLC
Files at ZSQR (Coeptis Therapeutics Holdings, Inc.). First filing -, latest -.
In brief
BSG Series CM, LLC files SEC Form 4 as 10% owner at ZSQR (Coeptis Therapeutics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; BSG Series CM, LLC has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | JOther Common Stock, $0.0001 par value | -41,521,276 | $0.00 | $0 | 0 | May 15, 2026 |
Questions about BSG Series CM, LLC
Answered from the filings on this page, as of the latest one.
Is BSG Series CM, LLC buying or selling?
BSG Series CM, LLC has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did BSG Series CM, LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and BSG Series CM, LLC has 0.
Where does BSG Series CM, LLC file Form 4?
BSG Series CM, LLC has filed Form 4 at ZSQR (Coeptis Therapeutics Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.